137 related articles for article (PubMed ID: 2419543)
1. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM
J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
[TBL] [Abstract][Full Text] [Related]
2. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
Bianchi BR; Miller TR; Witte DG; Lin CW
J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
[TBL] [Abstract][Full Text] [Related]
3. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of cholecystokinin-stimulated amylase release and cholecystokinin receptor binding in rat pancreatic acini.
Blevins GT; Doi R; Tangoku A; Chowdhury P; McKay D; Rayford PL
J Lab Clin Med; 1992 May; 119(5):566-73. PubMed ID: 1374786
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
7. Role of calcium in cholecystokinin-stimulated phosphoinositide breakdown in exocrine pancreas.
Pandol SJ; Thomas MW; Schoeffield MS; Sachs G; Muallem S
Am J Physiol; 1985 May; 248(5 Pt 1):G551-60. PubMed ID: 2581457
[TBL] [Abstract][Full Text] [Related]
8. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides.
Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A
J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin antagonists.
Maton PN; Jensen RT; Gardner JD
Horm Metab Res; 1986 Jan; 18(1):2-9. PubMed ID: 2419234
[TBL] [Abstract][Full Text] [Related]
10. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
11. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a cholecystokinin analogue with partial agonist activity.
Howard JM; Knight M; Jensen RT; Gardner JD
Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
[TBL] [Abstract][Full Text] [Related]
14. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
Chowdhury P; Rayford PL
Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
[TBL] [Abstract][Full Text] [Related]
15. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
Sarri E; Ramos B; Salido GM; Claro E
Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
18. Effect of cholecystokinin variant (CCK39) on dispersed acinar cells from guinea pig pancreas.
Sjodin L; Gardner JD
Gastroenterology; 1977 Nov; 73(5):1015-8. PubMed ID: 198332
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini.
Villanueva ML; Collins SM; Jensen RT; Gardner JD
Am J Physiol; 1982 Apr; 242(4):G416-22. PubMed ID: 6175230
[TBL] [Abstract][Full Text] [Related]
20. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
